Heart Disease Therapeutic Targets

Protein Name	Alternative Names	BioChemical Class / Role	Products (Cat NO)
			Protein	Antibody	Gene cDNA clones
VEGF	VEGF-A, RP1-261G23.1, MGC70609, MVCD1, VPF	VEGF(Vascular endothelial growth factor ), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. VEGF-A is important for the formation of blood vessels, such as during development or in pathological conditions.	11066-HNAB		HG10008-M, HG10009-M, HG10010-M, HG11066-M MG50159-M
PPIB					HG11004-M
FGFR1/CD331	FLT2, KAL2, BFGFR, CEK, FGFBR, FLG, FLJ99988, HBGFR, N-SAM, OGD	FGFR1 (Fibroblast growth factor receptor 1), also known as fms-related tyrosine kinase-2 (FLT2) and CD331, is a receptor tyrosine kinase whose ligands are specific members of the fibroblast growth factor family.Defects in FGFR1 are the cause of several deseases, such as Kallmann syndrome type 2 (KAL2), osteoglophonic dysplasia (OGD), as well as Pfeiffer syndrome (PF).	10616-H03H, 10616-H08H		HG10616-M, MG50186-M
CDK9/CDC2L4					HG10907-M
MAP3K13	LZK, MEKK13, MGC133196				HG10634-M
PLTP	HDLCQ9				HG11171-M
Carboxypeptidase A1	CPA1, CPA	Carboxypeptidase A1 is secreted as a pancreatic procarboxypeptidase. In contrast to procarboxypeptidase B which was always secreted by the pancreas as a monomer, procarboxypeptidase A occurs as a monomer and/or associated to one or two functionally different proteins, such as zymogen E, and is involved in zymogen inhibition.	10504-H08H		HG10504-M
Carboxypeptidase A2	CPA2	Carboxypeptidase A2 is a secreted pancreatic procarboxy-peptidase, and cleaves the C-terminal amide or ester bond of peptides that have a free C-terminal carboxyl group. The hydrolytic action of CPA2 was identified with a preference towards long substrates with aromatic amino acids in their C-terminal end, particularly tryptophan.	10499-H08H		HG10499-M
Carboxypeptidase A4	CPA4, CPA3				HG10789-M